| All patients (N = 228) | With AKI-RRT (N = 80) | Without AKI-RRT (N = 148) | p value |
---|---|---|---|---|
Age (years) | 55 ± 16 | 54 ± 14 | 56 ± 17 | 0.639 |
Male | 117 (51) | 45 (56) | 72 (49) | 0.331 |
APACHE II | 32 [29–37] | 35 [31–40] | 31 [28–35] | < 0.001 |
Ever smoker | 140 (61) | 50 (63) | 90 (61) | 0.887 |
Alcohol abuse | 56 (25) | 19 (24) | 37 (25) | 0.873 |
Chronic kidney disease | 37 (16) | 18 (23) | 19 (13) | 0.063 |
Vasopressor use | 128 (56) | 47 (59) | 81 (55) | 0.579 |
ARDS development | 111 (49) | 41 (51) | 70 (47) | 0.582 |
Ventilator-free days | 19 [0–24] | 6 [0–23] | 21 [1–25] | 0.001 |
ICU days | 8 [5–11] | 9 [6–13] | 7 [4–11] | 0.020 |
Hospital days | 13 [8–22] | 16 [9–26] | 11 [8–20] | 0.013 |
Died in hospital | 83 (36) | 38 (48) | 45 (30) | 0.014 |
Creatinine (mg/dl) | 1.43 [0.92–2.63] | 1.98 [1.15–4.06] | 1.21 [0.83–2.03] | < 0.001 |
sVE-cadherin (ng/ml) | 2697 [2110–3492] | 3052 [2341–3887] | 2543 [2058–3410] | 0.003 |